Arsenic trioxide as a novel anti-glioma drug: a review

Cell Mol Biol Lett. 2020 Sep 24:25:44. doi: 10.1186/s11658-020-00236-7. eCollection 2020.

Abstract

Arsenic trioxide has shown a strong anti-tumor effect with little toxicity when used in the treatment of acute promyelocytic leukemia (APL). An effect on glioma has also been shown. Its mechanisms include regulation of apoptosis and autophagy; promotion of the intracellular production of reactive oxygen species, causing oxidative damage; and inhibition of tumor stem cells. However, glioma cells and tissues from other sources show different responses to arsenic trioxide. Researchers are working to enhance its efficacy in anti-glioma treatments and reducing any adverse reactions. Here, we review recent research on the efficacy and mechanisms of action of arsenic trioxide in the treatment of gliomas to provide guidance for future studies.

Keywords: Anti-cancer mechanism; Arsenic trioxide; Glioma.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Apoptosis / drug effects
  • Arsenic Trioxide / therapeutic use*
  • Autophagy / drug effects
  • Glioma / drug therapy*
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy

Substances

  • Antineoplastic Agents
  • Arsenic Trioxide